Optiver Holding
PLSE icon

Optiver Holding’s Pulse Biosciences PLSE Stock Holding History

Optiver Holding’s Portfolio PLSE Stock Details PLSE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.45K Sell
160
-136
-46% -$2.51K ﹤0.01% 1593
2025
Q4 		$4.06K Hold
296
– – ﹤0.01% 1520
2025
Q3 		$5.24K Buy
+296
New +$4.68K ﹤0.01% 1704

Other funds holding PLSE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PCM
Portolan Capital Management Boston, Massachusetts $1.88B AUM 115.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
GAM
Griffin Asset Management New York $887M AUM 21.42% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $45.4B AUM 60.68% 1-Year Est. Return

Optiver Holding's PLSE Position: Q1 2026 in Review

Optiver Holding reduced its Pulse Biosciences (PLSE) stake by 46% in Q1 2026, selling an estimated $2.51K and leaving 160 shares worth $3.45K. The position accounts for ﹤0.01% of the portfolio, ranked #1593.

Optiver Holding first reported a position in PLSE in Q3 2025 and has held it in 3 quarters since. The position peaked at $5.24K in Q3 2025. 96 funds tracked by Wall St. Rank hold PLSE as of Q1 2026.

  • Optiver Holding held 160 shares of Pulse Biosciences worth $3.45K as of Q1 2026.
  • Optiver Holding sold 136 Pulse Biosciences shares in Q1 2026, an estimated $2.51K.
  • Pulse Biosciences made up ﹤0.01% of Optiver Holding's portfolio in Q1 2026, its #1593 holding.
  • Optiver Holding first reported a position in Pulse Biosciences in Q3 2025 and has held it in 3 quarters since.
  • Optiver Holding's Pulse Biosciences position peaked at $5.24K in Q3 2025.
  • 96 funds tracked by Wall St. Rank held Pulse Biosciences as of Q1 2026.

Based on Optiver Holding's 13F filing for Q1 2026, filed 15 May 2026.